Vizient, Inc. Applauds FDAs Heightened Focus on Preventing Drug Shortages

Vizient,
Inc. applauds the U.S. Food and Drug Administration (FDA) for
forming a new drug shortages task force and advancing long-term
solutions to prevent shortages.

Stable and reliable supply, along with cost and safety, are always top
priorities for Vizient. In addition to regular communication and
education to our health care members, for years we’ve worked to mitigate
the impact of shortages and price spikes through innovative contracting
strategies and alternative drug therapies, as well as by being actively
involved in advocating for legislative language to encourage competition.

“Access to affordable drugs is one of the most critical challenges
facing health care today,” says Dan Kistner, senior vice president,
pharmacy solutions at Vizient. “For over a decade, drug shortages have
plagued hospitals and become a routine obstacle around which providers
have had to navigate. It is a natural extension of Vizient’s mission to
work collaboratively with all stakeholders to find innovative solutions
to prevent drug shortages.” Vizient is committed to working with the FDA
and other stakeholders to improve the safety and reliability of the
supply chain.

Vizient is the nation’s largest health care performance improvement
company serving a diverse membership that includes academic medical
centers, pediatric facilities, community hospitals, integrated health
care delivery networks and non-acute health care providers.

About Vizient, Inc.

Vizient, Inc., the largest member-driven health care performance
improvement company in the country, provides innovative data-driven
solutions, expertise and collaborative opportunities that lead to
improved patient outcomes and lower costs. Vizient’s diverse membership
base includes academic medical centers, pediatric facilities, community
hospitals, integrated health delivery networks and non-acute health care
providers and represents approximately $100 billion in annual purchasing
volume. The Vizient brand identity represents the integration of VHA
Inc., University HealthSystem Consortium and Novation, which combined in
2015, as well as MedAssets’ Spend and Clinical Resource Management (SCM)
segment, including Sg2, which was acquired in 2016. In 2018, Vizient
again received a World’s Most Ethical Company designation from the
Ethisphere Institute. Vizient’s headquarters are in Irving, Texas, with
locations in Chicago and other cities across the United States. Please
visit www.vizientinc.com
as well as our newsroom,
blog,
Twitter,
LinkedIn
and YouTube
pages for more information about the company.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180713005297/en/

Leave a Comment